US Patent 10179160 Therapeutic compositions for the treatment of dry eye disease

Patent 10179160 was granted and assigned to Schepens Eye Research Institute Inc. on January, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Schepens Eye Research Institute Inc.

Current Assignee

‌

Schepens Eye Research Institute Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10179160

Date of Patent

January 15, 2019

Patent Application Number

15083907

Date Filed

March 29, 2016

Patent Citations Received

‌

US Patent 11596641 Methods and compositions for treating meibomian gland dysfunction

Patent Primary Examiner

‌

Marcela M Cordero Garcia

Patent abstract

Described herein are materials and methods of treating dry eye disease in a subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10179160 Therapeutic compositions for the treatment of dry eye disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API